Related Experiment Video
Updated: May 30, 2026

05:53
Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry
Published on: June 21, 2018
Design considerations for massively parallel sequencing studies of complex human disease
Bing-Jian Feng1, Sean V Tavtigian, Melissa C Southey
1Department of Dermatology, University of Utah School of Medicine, Salt Lake City, Utah, United States of America.
Plos One
|August 19, 2011
Summary
Massively Parallel Sequencing (MPS) aids complex disease gene discovery, but careful study design is crucial. Simulations show filtering strategies can reduce false positives but risk missing true susceptibility genes.
Area of Science:
- Genomics
- Complex Disease Genetics
- Bioinformatics
Background:
- Massively Parallel Sequencing (MPS) is cost-effective for whole exome/genome sequencing.
- Complex diseases present challenges like heterogeneity and genotype-phenotype complexity.
- Identifying true disease susceptibility genes requires robust analytical strategies.
Purpose of the Study:
- To compare various Massively Parallel Sequencing (MPS) study designs for complex diseases.
- To evaluate the impact of different filtering strategies on gene discovery.
- To provide guidelines for optimizing MPS study designs in complex disease research.
Main Methods:
- Simulation-based analyses were conducted to assess different MPS sequencing strategies.
- Factors examined included genetic architecture, sample size, and individual selection within pedigrees.
- A two-stage design with cost-function evaluation was employed.
Main Results:
- Filtering variants found in multiple pedigrees or individuals reduces false positives but can lead to over-filtering.
- Sequencing more than two individuals per pedigree generally reduces power without cost benefits.
- No single strategy is universally optimal, but simulations offer valuable design insights.
Conclusions:
- Careful selection of filtering strategies is essential for Massively Parallel Sequencing in complex disease genetics.
- Optimizing sample size and pedigree structure is critical for maximizing discovery power.
- Simulation studies are vital for guiding the design of effective MPS studies for complex traits.
More Related Videos
Related Concept Videos
Next-generation Sequencing
The first human genome sequencing project cost $2.7 billion and was declared complete in 2003, after 15 years of international cooperation and collaboration between several research teams and funding agencies. Today, with the advent of next-generation sequencing technologies, the cost and time of sequencing a human genome have dropped over 100 fold.
Next-Generation Sequencing Methods
Although all next-generation methods use different technologies, they all share a set of standard features.
Next-Generation Sequencing Methods
Although all next-generation methods use different technologies, they all share a set of standard features.
RNA-seq
RNA sequencing, or RNA-Seq, is a high-throughput sequencing technology used to study the transcriptome of a cell. Transcriptomics helps to interpret the functional elements of a genome and identify the molecular constituents of an organism. Additionally, it also helps in understanding the development of an organism and the occurrence of diseases.
Before the discovery of RNA-seq, microarray-based methods and Sanger sequencing were used for transcriptome analysis. However, while microarray-based...
Before the discovery of RNA-seq, microarray-based methods and Sanger sequencing were used for transcriptome analysis. However, while microarray-based...
Genome-wide Association Studies-GWAS
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...

